An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors

This study is currently recruiting participants.
Verified January 2014 by InnoPharmax Inc.
Sponsor:
Information provided by (Responsible Party):
InnoPharmax Inc.
ClinicalTrials.gov Identifier:
NCT01678690
First received: August 29, 2012
Last updated: January 16, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)